Xinru Du

机构：Zhejiang Sci-Tech University, Shanxi Normal University · ORCID：0000-0002-7282-1997

发表论文 34 篇 · 总被引 328 次 · h-index 8

代表论文

• Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies (2020 · Cancer Cell · 被引 191)
• PKP/PVP combine chemotherapy in the treatment of multiple myeloma patients with vertebral pathological fractures: minimum 3-year follow-up of 108 cases (2019 · Journal of Orthopaedic Surgery and Research · 被引 13)
• Modified tibial cortex transverse transport for diabetic foot ulcers with Wagner grade ≥ II: a study of 98 patients (2024 · Frontiers in Endocrinology · 被引 11)
• Myeloma extracellular vesicle-derived RAGE increases inflammatory responses and myotube atrophy in multiple myeloma through activation of the TLR4/NF-κB p65 pathway (2023 · APOPTOSIS · 被引 10)
• Learning curve of tibial cortex transverse transport: a cumulative sum analysis (2023 · Journal of Orthopaedic Surgery and Research · 被引 8)
• Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus (2024 · European Journal of Pharmacology · 被引 7)